Target intelligence / Profile preview

MicroRNA 3184-3p (miR-3184-3p)

Target
miR-3184-3p
Molecular classification
microRNA, Non-coding RNA
01

Overview

MicroRNA 3184-3p (miR-3184-3p) is a small, non-coding RNA molecule approximately 22 nucleotides in length that functions primarily in the post-transcriptional regulation of gene expression by binding to target messenger RNAs. It is notably enriched in cerebrospinal fluid exosomes of glioma patients and acts as an oncogenic regulator by promoting cell proliferation, migration, invasion, reducing apoptosis, and inducing epithelial-mesenchymal transition in cancer cells. In glioma, exosomal miR-3184-3p also contributes to tumor immune evasion by polarizing macrophages to a tumor-supportive M2-like phenotype. Additionally, miR-3184-3p levels are modulated in inflammatory diseases such as psoriasis, where it has been implicated in autophagy regulation and keratinocyte proliferation. It is not a protein-coding therapeutic target (like a receptor or enzyme) but is a regulatory RNA molecule with potential as a biomarker and indirect drug target[1][2][4][5][7][9].

Other names
hsa-miR-3184-3pmiRNA-3184-3p
02

Mechanism of action

Upregulation or downregulation by exogenous agents (e.g., PSORI-CM01 increases miR-3184-3p levels to modulate autophagy and proliferation) RNA interference or antagomir/inhibitor strategies (preclinical/experimental)

03

Biological functions

Regulation of gene expressionPromotion of cell proliferationPromotion of cell migrationPromotion of cell invasionInduction of epithelial-mesenchymal transition (EMT)Immune modulation via macrophage polarization (M2-like)Regulation of apoptosisRegulation of autophagy
04

Disease associations

Cancer (notably glioma and potentially breast cancer)Inflammatory disease (psoriasis)
05

Safety considerations

Off-target effects due to broad impact of miRNA on many gene targetsPossible immune modulation, as it promotes M2-like macrophage polarizationOncogenic potential by promoting proliferation, migration, and invasion in tumors
06

Interacting drugs

PSORI-CM01 (Traditional Chinese Medicine compound)

1 more in the full profile.

07

Biomarkers

Enriched in cerebrospinal fluid exosomes of glioma patients—potential liquid biopsy biomarker for glioma diagnosis and monitoringModulation in psoriasis patient blood cells

Beyond the preview

Go deeper on MicroRNA 3184-3p (miR-3184-3p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3184-3p (miR-3184-3p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call